There's a new pill and new ways to pay for the weight-loss drugs known as GLP-1s.
Vanda Pharmaceuticals has received FDA approval for Nereus (tradipitant), an oral NK-1 receptor antagonist developed to prevent motion-induced vomiting. The approval makes Nereus the first new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback